Boston Scientific Corporation (BSX)
Healthcare • Medical Devices
StockNYSEUnited StatesUS1011371077
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Boston Scientific Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:06. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 10 Feb 2027 08:00 | 0.78 | — | — | Upcoming |
| 28 Oct 2026 06:00 | 0.72 | 0.73 | +0.9% | In line |
| 29 Jul 2026 06:00 | 0.83 | 0.86 | +3.9% | Beat |
| 22 Apr 2026 06:00 | 0.79 | 0.80 | +1.6% | Beat |
| 04 Feb 2026 06:00 | 0.78 | 0.80 | +2.4% | Beat |
| 22 Oct 2025 06:00 | 0.71 | 0.75 | +5.1% | Beat |
| 23 Jul 2025 06:00 | 0.73 | 0.75 | +3.4% | Beat |
| 23 Apr 2025 06:00 | 0.67 | 0.75 | +11.5% | Beat |
| 05 Feb 2025 06:00 | 0.66 | 0.70 | +6.6% | Beat |
| 23 Oct 2024 06:00 | 0.59 | 0.63 | +7.1% | Beat |
| 24 Jul 2024 06:00 | 0.58 | 0.62 | +6.5% | Beat |
| 24 Apr 2024 06:00 | 0.51 | 0.56 | +9.1% | Beat |
| 31 Jan 2024 06:00 | 0.51 | 0.55 | +7.3% | Beat |
| 26 Oct 2023 06:00 | 0.48 | 0.50 | +4.7% | Beat |
| 27 Jul 2023 06:00 | 0.49 | 0.53 | +8.2% | Beat |
| 26 Apr 2023 06:00 | 0.43 | 0.47 | +8.6% | Beat |
| 01 Feb 2023 06:00 | 0.47 | 0.45 | -4.6% | Miss |
| 26 Oct 2022 06:00 | 0.44 | 0.43 | -2.6% | Miss |
| 27 Jul 2022 06:00 | 0.42 | 0.44 | +4.0% | Beat |
| 27 Apr 2022 06:00 | 0.39 | 0.39 | +1.2% | Beat |
| 02 Feb 2022 06:00 | 0.44 | 0.45 | +2.5% | Beat |
| 27 Oct 2021 06:00 | 0.40 | 0.41 | +3.7% | Beat |
| 27 Jul 2021 06:00 | 0.37 | 0.40 | +7.3% | Beat |
| 28 Apr 2021 06:00 | 0.31 | 0.37 | +21.1% | Beat |
| 03 Feb 2021 06:00 | 0.31 | 0.23 | -26.0% | Miss |
| 28 Oct 2020 06:00 | 0.25 | 0.37 | +49.7% | Beat |
| 29 Jul 2020 06:00 | -0.02 | 0.08 | +436.6% | Beat |
| 29 Apr 2020 06:00 | 0.32 | 0.28 | -11.2% | Miss |
| 05 Feb 2020 06:00 | 0.44 | 0.46 | +4.5% | Beat |
| 23 Oct 2019 06:00 | 0.38 | 0.39 | +1.9% | Beat |
| 24 Jul 2019 06:00 | 0.38 | 0.39 | +2.6% | Beat |
| 24 Apr 2019 06:00 | 0.36 | 0.35 | -1.8% | Miss |
| 06 Feb 2019 06:00 | 0.36 | 0.39 | +9.2% | Beat |
| 24 Oct 2018 06:00 | 0.34 | 0.35 | +3.0% | Beat |
| 25 Jul 2018 06:00 | 0.34 | 0.41 | +19.6% | Beat |
| 25 Apr 2018 06:00 | 0.32 | 0.33 | +4.8% | Beat |
| 01 Feb 2018 06:00 | 0.34 | 0.34 | -0.8% | In line |
| 26 Oct 2017 06:00 | 0.31 | 0.31 | +0.8% | In line |
| 27 Jul 2017 06:00 | 0.31 | 0.32 | +2.8% | Beat |
| 27 Apr 2017 06:00 | 0.30 | 0.29 | -3.4% | Miss |
| 02 Feb 2017 06:00 | 0.29 | 0.30 | +4.8% | Beat |
| 26 Oct 2016 06:00 | 0.27 | 0.27 | +1.0% | In line |
| 28 Jul 2016 06:00 | 0.27 | 0.27 | +1.9% | Beat |
| 27 Apr 2016 06:00 | 0.24 | 0.28 | +15.8% | Beat |
| 04 Feb 2016 06:00 | 0.25 | 0.26 | +5.5% | Beat |
| 28 Oct 2015 06:00 | 0.23 | 0.24 | +6.4% | Beat |
| 23 Jul 2015 07:00 | 0.21 | 0.22 | +2.6% | Beat |
| 28 Apr 2015 07:00 | 0.21 | 0.21 | +2.2% | Beat |
| 04 Feb 2015 07:00 | 0.22 | 0.22 | +2.1% | Beat |
| 22 Oct 2014 07:00 | 0.20 | 0.20 | +2.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 20.1B | +19.9% | 2.9B | 14.4% | 1.94 | +55.2% | 3.4B |
| 2024 | 16.7B | +17.6% | 1.9B | 11.1% | 1.25 | +16.8% | 2.4B |
| 2023 | 14.2B | +12.3% | 1.6B | 11.2% | 1.07 | +137.8% | 1.7B |
| 2022 | 12.7B | — | 698M | 5.5% | 0.45 | — | 914M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 42.07 | 46.97 | 41.90 | 44.42 | +5.82% | 172,470,573 | |
| Oct 2026 | 43.51 | 46.16 | 39.57 | 41.98 | -3.83% | 407,021,100 | |
| Sep 2026 | 49.12 | 49.66 | 42.72 | 43.65 | -9.63% | 439,258,600 | |
| Aug 2026 | 47.82 | 52.99 | 46.09 | 48.30 | +3.36% | 407,806,600 | |
| Jul 2026 | 43.21 | 47.16 | 42.20 | 46.73 | +9.49% | 431,442,700 | |
| Jun 2026 | 48.31 | 50.14 | 42.25 | 42.68 | -11.65% | 460,774,000 | |
| May 2026 | 57.93 | 58.51 | 48.13 | 48.31 | -16.14% | 424,418,500 | |
| Apr 2026 | 63.72 | 66.88 | 56.05 | 57.61 | -8.19% | 374,347,800 | |
| Mar 2026 | 76.28 | 76.68 | 61.25 | 62.75 | -18.35% | 326,830,700 | |
| Feb 2026 | 93.15 | 94.18 | 72.69 | 76.85 | -17.83% | 401,547,900 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Should Boston Scientific (BSX) Investors Worry About These FDA Class II Recalls? (opens in a new tab) Simply Wall St. · 11 Nov 2026 17:15
- Boston Scientific (BSX) Stock May Be 38% Undervalued Following WATCHMAN Trial News (opens in a new tab) Simply Wall St. · 11 Nov 2026 16:11
- Boston Scientific Targets Long-Term Growth as Key Businesses Face Pressure Through 2027 (opens in a new tab) MarketBeat · 11 Nov 2026 15:15
- Boston Scientific Corporation (BSX) Presents at Stifel 2026 Healthcare Conference 2026 Transcript (opens in a new tab) SeekingAlpha · 11 Nov 2026 11:39
- Podcast: Driving DBS access for Parkinson’s patients in the UK and Europe (opens in a new tab) Medical Device Network · 10 Nov 2026 16:32
- Wall Street Analysts Look Bullish on Boston Scientific (BSX): Should You Buy? (opens in a new tab) Zacks · 10 Nov 2026 13:30
- A Fund With $2 Billion in US Equities Bought These 3 Stocks (opens in a new tab) TIKR · 10 Nov 2026 07:43
- What Could Go Wrong At Boston Scientific From Here? (opens in a new tab) Trefis · 07 Nov 2026 10:06
- S&P revises Boston Scientific outlook to negative on franchise pressures (opens in a new tab) Investing.com · 06 Nov 2026 22:28
- Bioelectronic Medicine and Neural Interface Devices Global Market Report 2026 | Capture 20.9% CAGR as Abbott, Boston Scientific, Neuralink and Science Advance Closed-Loop Systems (opens in a new tab) 05 Nov 2026 15:39
- Here is What to Know Beyond Why Boston Scientific Corporation (BSX) is a Trending Stock (opens in a new tab) Zacks · 05 Nov 2026 13:00
- Boston Scientific, Blackstone agree to $455M deal to co-fund heart pump development (opens in a new tab) MedTech Dive · 05 Nov 2026 11:04
- RevMedica Appoints Former Boston Scientific Executive Mike Jones as Chief Executive Officer (opens in a new tab) 04 Nov 2026 16:04
- BSX Q3 Results Reset Growth Expectations as 2027 Outlook Stays Weak (opens in a new tab) Zacks · 04 Nov 2026 13:55
- Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years (opens in a new tab) Benzinga · 04 Nov 2026 12:30
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 44.20 USD
- Market cap
- 64.1B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow BSX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.